Protalix BioTherapeutics, Inc. (PLX) Operating income 2016–2025
Protalix BioTherapeutics, Inc. (PLX) annual operating income history from SEC filings — each fiscal year as reported.
-$5.5MFY2025 · since FY2016: -$33.2M → -$5.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$5.5M | -240.4% |
| FY2024 | $3.9M | -62.6% |
| FY2023 | $10.5M | +180.4% |
| FY2022 | -$13.0M | +36.4% |
| FY2021 | -$20.5M | -855.1% |
| FY2020 | $2.7M | +125.3% |
| FY2019 | -$10.7M | +44.5% |
| FY2018 | -$19.3M | +44.1% |
| FY2017 | -$34.5M | -4.1% |
| FY2016 | -$33.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice